Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer
The combination of nab-paclitaxel, cisplatin/nedaplatin, and tegafur/gimeracil/oteracil is a safe induction chemotherapy for treating hypopharyngeal cancer.
Authors
- Mafei Kang
- Guangteng Wu (ORCID: https://orcid.org/0009-0000-6003-8885)
- Yunyan Mo
- Xiaosong He
- Cailing Jiang
- Xi Qin (ORCID: https://orcid.org/0000-0002-1154-5634)
- Shengyuan Xu
- Feng Xue (ORCID: https://orcid.org/0000-0002-5060-7324)
- Zhen‐Ya Li (ORCID: https://orcid.org/0000-0002-5034-1677)
- Lin Zhu (ORCID: https://orcid.org/0009-0000-6418-9736)
- Lieyin Xu
Institutions
- Guilin Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fonc.2025.1504658
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00